Compromised Lung Volume and Hemostatic Abnormalities in COVID-19 Pneumonia: Results from an Observational Study on 510 Consecutive Patients.

Ezio Lanza Maria Elisa Mancuso Gaia MessanaPaola FerrazziCostanza LisiPierpaolo Di MiccoStefano BarcoLuca BalzariniCorrado Lodigiani

Published in: Journal of clinical medicine (2021)

Hemostatic abnormalities in patients affected by COVID-19 correlate with the severity of lung injury as measured by %CL. Our results underline the pathogenetic role of hemostasis in COVID-19 pneumonia beyond the presence of clinically evident thromboembolic complications.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
patient reported outcomes
respiratory syndrome coronavirus